Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lifevantage Corporation stock logo
LFVN
Lifevantage
$6.35
+2.4%
$6.41
$3.90
$11.71
$77.67M0.7349,553 shs50,994 shs
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$2.99
$3.19
$2.87
$10.52
$238.14M2.09349,758 shs609,158 shs
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$14.12
-1.6%
$16.95
$12.57
$30.84
$264.95M0.68197,979 shs337,822 shs
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
$2.51
-4.4%
$3.09
$2.15
$10.28
$246.71M-1.5473,377 shs162,253 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lifevantage Corporation stock logo
LFVN
Lifevantage
+2.42%+2.92%-2.31%-0.94%-40.93%
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
0.00%-1.64%-5.68%-14.57%-68.95%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
-1.64%-6.10%+6.65%-25.71%-53.12%
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
-5.10%-5.31%-15.33%-21.07%-74.52%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lifevantage Corporation stock logo
LFVN
Lifevantage
$6.35
+2.4%
$6.41
$3.90
$11.71
$77.67M0.7349,553 shs50,994 shs
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$2.99
$3.19
$2.87
$10.52
$238.14M2.09349,758 shs609,158 shs
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$14.12
-1.6%
$16.95
$12.57
$30.84
$264.95M0.68197,979 shs337,822 shs
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
$2.51
-4.4%
$3.09
$2.15
$10.28
$246.71M-1.5473,377 shs162,253 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lifevantage Corporation stock logo
LFVN
Lifevantage
+2.42%+2.92%-2.31%-0.94%-40.93%
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
0.00%-1.64%-5.68%-14.57%-68.95%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
-1.64%-6.10%+6.65%-25.71%-53.12%
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
-5.10%-5.31%-15.33%-21.07%-74.52%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lifevantage Corporation stock logo
LFVN
Lifevantage
2.00
Hold$5.50-13.39% Downside
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
3.00
Buy$10.33245.60% Upside
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
1.00
SellN/AN/A
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest LFVN, USNA, YSG, and NAGE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
Boost Price TargetHold$5.00 ➝ $6.00
8/21/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
Reiterated RatingHold (C)
8/13/2026
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
Reiterated RatingSell (D-)
8/6/2026
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
DowngradeHoldStrong Sell
8/5/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Reiterated RatingBuy
8/5/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Set Price Target$10.00
7/17/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Reiterated RatingHold (C)
7/6/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
UpgradeStrong-Buy
7/1/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Reiterated RatingBuy
6/24/2026
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
Reiterated RatingSell (D)
(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lifevantage Corporation stock logo
LFVN
Lifevantage
$182.59M0.44$0.81 per share7.83$2.66 per share2.39
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$129.42M1.84$0.20 per share14.74$0.96 per share3.11
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$925.26M0.28$4.07 per share3.47$29.16 per share0.48
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
$614.62M0.38$0.01 per share328.70$4.57 per share0.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lifevantage Corporation stock logo
LFVN
Lifevantage
$5.07M$0.4015.8811.98N/A2.78%21.56%11.62%11/3/2026 (Estimated)
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$17.38M$0.1816.6121.36N/A12.39%17.95%13.17%N/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$10.76M-$1.21N/A7.971.57-2.43%3.41%2.50%10/28/2026 (Estimated)
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
-$11.56M-$0.32N/AN/AN/A-4.63%-7.26%-5.42%11/24/2026 (Estimated)

Latest LFVN, USNA, YSG, and NAGE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/3/2026Q2 2026
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
N/A-$0.14N/A-$0.15N/A$168.12 million
8/27/2026Q4 2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.1150$0.11-$0.0050$0.10$44.00 million$42.38 million
8/14/2026Q2 2026
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
N/A-$0.14N/A-$0.15N/A$168.12 million
8/4/2026Q2 2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$0.01$0.01N/A$0.01$29.95 million$29.78 million
8/4/2026Q2 2026
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$0.43-$0.07-$0.50-$1.16$235.00 million$223.27 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.203.15%N/A50.00%3 Years
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
N/AN/AN/AN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/AN/AN/AN/AN/A
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
N/AN/AN/AN/AN/A

Latest LFVN, USNA, YSG, and NAGE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/20/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
quarterly$0.053.21%9/1/20269/1/20269/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lifevantage Corporation stock logo
LFVN
Lifevantage
N/A
1.89
1.09
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
N/A
6.50
5.13
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/A
2.66
1.84
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
0.15
3.70
2.78

Institutional Ownership

CompanyInstitutional Ownership
Lifevantage Corporation stock logo
LFVN
Lifevantage
35.32%
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
15.41%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
54.25%
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
N/A

Insider Ownership

CompanyInsider Ownership
Lifevantage Corporation stock logo
LFVN
Lifevantage
21.95%
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
10.00%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
0.82%
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
29.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lifevantage Corporation stock logo
LFVN
Lifevantage
22312.53 million9.78 millionOptionable
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
11779.64 million71.68 millionN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
1,57018.48 million18.33 millionOptionable
Yatsen Holding Limited Sponsored ADR stock logo
YSG
Yatsen
1,62393.81 million66.60 millionOptionable

Recent News About These Companies

Yatsen (NYSE:YSG) Downgraded by Wall Street Zen to Sell
Yatsen Holding Q2 Loss Widens, Shares Down
Yatsen Q2 Earnings Call Highlights
Yatsen Announces Second Quarter 2026 Financial Results
Yatsen (YSG) Q1 2026 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lifevantage stock logo

Lifevantage NASDAQ:LFVN

$6.35 +0.15 (+2.42%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$6.36 +0.01 (+0.08%)
As of 09/18/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

Niagen Bioscience stock logo

Niagen Bioscience NASDAQ:NAGE

$2.99 0.00 (0.00%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$3.02 +0.03 (+1.00%)
As of 09/18/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

USANA Health Sciences stock logo

USANA Health Sciences NYSE:USNA

$14.12 -0.23 (-1.57%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$14.16 +0.04 (+0.32%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Yatsen stock logo

Yatsen NYSE:YSG

$2.51 -0.12 (-4.41%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$2.56 +0.04 (+1.63%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Yatsen Holding Limited, together with its subsidiaries, engages in the development and sale of beauty products under the Perfect Diary, Little Ondine, Pink Bear, Abby's Choice, GalÃnic, DR.WU, Eve Lom, and EANTiM brands in the People's Republic of China. The company offers color cosmetics for lips, eyes, and face; skin care products, including face serums and creams, eye creams, masks, toners, makeup removers, cleansers, ampoules, and anti-acne patches; and beauty tools and kits, sunscreen products, and beauty devices. It sells its products through stores and online channel. The company was formerly known as Mangrove Bay Ecommerce Holding (Cayman) and changed its name to Yatsen Holding Limited in January 2019. Yatsen Holding Limited was founded in 2016 and is headquartered in Guangzhou, China.